BTK and primary central nervous system lymphoma: This review includes five main topics: i) an update on management of PCNSL; ii) the BCR/BTK signaling pathway in PCNSL; iii) the clinical application of BTKi in PCNSL; iv) the mechanism of resistance to BTKi and management; v) the side effects of BTKi.